Evidence map›Paper›PMID 42194647›Full record

ArticleJournal of clinical medicine2026

Salivary Galectin-9 Levels in Primary Sjögren's Disease: An Observational Cross-Sectional Case-Control Study.

Elif İnanç, Servet Yolbaş, Sezgin Zontul, Fuat Albayram, Mesude Seda Aydoğdu, Zeynep Kaya, Faruk Dişli, Cihat Uçar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elif İnançDivision of Rheumatology, Department of Internal Medicine, Van Training and Research Hospital, University of Health Sciences, 65300 Van, Turkey.ORCID 0009-0008-5911-6864
Servet YolbaşDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.ORCID 0000-0001-8516-9769
Sezgin ZontulDivision of Rheumatology, Department of Physical Therapy and Rehabilitation, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.ORCID 0000-0001-5730-2286
Fuat AlbayramDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Mesude Seda AydoğduDivision of Rheumatology, Department of Internal Medicine, Malatya Training and Research Hospital, 44330 Malatya, Turkey.
Zeynep KayaDivision of Rheumatology, Department of Internal Medicine, Istanbul Training and Research Hospital, 34098 Istanbul, Turkey.ORCID 0000-0002-2048-0721
Faruk DişliDepartment of Physical Therapy and Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Bingol University, 12000 Bingol, Turkey.
Cihat UçarDepartment of Physiology, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Turkey.ORCID 0000-0003-3278-7779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerdisease activitygalectin-9primary Sjögren’s disease

Identifiers

PMID42194647
PMCPMC13207240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.